KalVista Pharmaceuticals

Small molecule plasma kallikrein inhibitors for the treatment of diabetic macular edema (DME).

Get a Demo and See the Full Profile

Get a demo today to see profiles of KalVista Pharmaceuticals plus 6038 other startups.

Learn More About KalVista Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More